肝星状细胞
PI3K/AKT/mTOR通路
肝纤维化
细胞生物学
信号转导
癌症研究
纤维化
化学
医学
内科学
生物
作者
Linxiang Liu,Bimin Li,Yue Zhang,Yuan Nie,Wang Zhang,Peng Chen,Chenkai Huang,Xuan Zhu
标识
DOI:10.1016/j.jcmgh.2025.101548
摘要
Background & Aims Liver fibrosis, driven by chronic injury, hinges on hepatic stellate cells (HSCs) activation. Microfibrillar-associated protein 4 (MFAP4), an extracellular matrix protein critical for elastic fiber assembly, is up-regulated in hepatic fibrosis, yet its mechanistic role remains unclear. Methods Liver fibrosis was induced in wild-type and Mfpa4 knockout mice using CCl 4 and TAA, whereas LX-2 cells were activated with transforming growth factor-β1. Bioinformatics analysis, histopathology, double immunofluorescence, flow cytometry, Transwell coculture systems, Western blot, and quantitative polymerase chain reaction were used to identify the primary intrahepatic cell types expressing MFAP4 and assess its effects on HSCs activation and apoptosis. Results MFAP4 is up-regulated in cirrhotic livers and is actively expressed in HSCs. Single-cell RNA sequencing analysis and Transwell coculture experiments revealed that the profibrotic effects of MFAP4 were primarily mediated through HSCs rather than hepatocytes. Inhibition of MFAP4 significantly reduces the expression of fibrosis markers in HSCs, inhibits their proliferation and migration, whereas overexpression of MFAP4 results in the opposite effect, accompanied by enhanced apoptosis resistance. In mouse models, global knockout of Mfap4 significantly alleviates CCl 4 - and TAA-induced liver fibrosis. Mechanistic analysis reveals that MFAP4 binds to integrin αvβ3 on the HSCs membrane, activating the FAK/PI3K/NFκB signaling pathway, which promotes HSC activation and survival, ultimately exacerbating liver fibrosis. Moreover, MFAP4 mediates a self-sustaining feedback loop via integrin αvβ3, maintaining HSCs activation and further promoting fibrosis progression. Conclusions MFAP4 governs HSCs activation and apoptosis resistance via integrin αvβ3-dependent FAK/PI3K/NFκB signaling. Targeting MFAP4 mitigates fibrosis by altering HSCs fate.
科研通智能强力驱动
Strongly Powered by AbleSci AI